<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Andrew&#039;s Blog</title>
	<atom:link href="http://blog.patientpower.info/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.patientpower.info</link>
	<description>A respected patient-advocate’s commentary on today’s health issues and people affected by them</description>
	<lastBuildDate>Tue, 21 May 2013 20:04:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>A Key to Cancer Hope You Should Know</title>
		<link>http://blog.patientpower.info/2013/05/21/a-key-to-cancer-hope-you-should-know/</link>
		<comments>http://blog.patientpower.info/2013/05/21/a-key-to-cancer-hope-you-should-know/#comments</comments>
		<pubDate>Tue, 21 May 2013 20:04:13 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Coping]]></category>
		<category><![CDATA[hope]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[Social Work]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=2012</guid>
		<description><![CDATA[<p>Do you have resources to deal with cancer that go beyond understanding treatment? Patients like me certainly spend a lot of time talking about treatments, and research into better treatments, which makes a lot of sense. But that’s just part of the cancer journey. Patients and caregivers also have personal struggles, often a family struggle, [...]]]></description>
				<content:encoded><![CDATA[<p>Do you have resources to deal with cancer that go beyond understanding treatment? Patients like me certainly spend a lot of time talking about treatments, and research into better treatments, which makes a lot of sense. But that’s just part of the cancer journey. Patients and caregivers also have personal struggles, often a family struggle, to cope, move through the cancer experience and to maintain hope – as well as enjoy the best of every day as it comes.</p>
<p>Physicians have little training to help us with that. It&#8217;s not really their job. But there are others who can help a great deal. In my experience the very best are specialized oncology social workers. You can find them at most larger cancer centers and sometimes thru private practices or support organizations. At major medical centers they often find you, at others you may have to ask. Their job is to help you get to a better place, no matter what the prognosis, and to help bring in other resources, as needed.</p>
<div id="attachment_2013" class="wp-caption alignright" style="width: 129px"><img class="size-full wp-image-2013" alt="Brianna Garrison" src="http://blog.patientpower.info/wp-content/uploads/2013/05/bio_brianna-garrison_a.jpg" width="119" height="155" /><p class="wp-caption-text">Brianna Garrison</p></div>
<p>Recently I met a terrific oncology social worker, Brianna Garrison, MSW, LMSW<strong>,</strong> who works with patients at MD Anderson Cancer Center in Houston. She was part of a town meeting for myeloma patients, and her advice cuts across all cancers. I urge you to watch this interview with her, <a href="http://www.patientpower.info/video/brianna-garrison-a-social-worker-s-advice-for-coping-with-myeloma/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MMY-2013&amp;utm_content=inline" target="_blank">Brianna Garrison: A Social Worker&#8217;s Advice</a>. She&#8217;s a wonderful example of what an oncology social worker has to offer the newly diagnosed or anyone down the road on their cancer journey, and their family.</p>
<p>As she points out, and as it became clear from our discussions with myeloma experts like Drs. <a href="http://www.patientpower.info/bio/robert-orlowski-m-d-ph-d/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MMY-2013&amp;utm_content=inline" target="_blank">Robert Orlowski</a> and <a href="http://www.patientpower.info/bio/shaji-kumar-m-d/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MMY-2013&amp;utm_content=inline" target="_blank">Shaji Kumar</a>, myeloma is a cancer where so much is happening in treatment and research that it should be emotionally uplifting for patients and their families, if only you have the help you need to see what&#8217;s positive. Dedicated oncology social workers like Brianna can help tremendously.</p>
<p>In so many cancers – certainly not all, but quite a few – people are living and living well. I am an example. For many blood-related cancers, and others that can be genetically targeted, patients who would earlier have had a shortened life or a poorer quality of life are living very well. An oncology social worker can help give you perspective. And if your diagnosis is in a condition where less progress has been made just yet even then a social worker can help you cope and get the help you need to make your days the best they can be.</p>
<p>Brianna Garrison helps people at MD Anderson and there are people just like her at other cancer centers and, often, available through oncology practices and support organizations. Call them or ask your doctor or nurse for names. Specialists like oncology social workers are key members of the cancer care team you should not overlook.</p>
<p>Wishing you and your family the best of health!<br />
Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/05/21/a-key-to-cancer-hope-you-should-know/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Angelina Jolie: Cancer Prevention to the Max</title>
		<link>http://blog.patientpower.info/2013/05/15/angelina-jolie-cancer-prevention-to-the-max/</link>
		<comments>http://blog.patientpower.info/2013/05/15/angelina-jolie-cancer-prevention-to-the-max/#comments</comments>
		<pubDate>Wed, 15 May 2013 17:54:19 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[angelina jolie]]></category>
		<category><![CDATA[braca2]]></category>
		<category><![CDATA[brca1]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[ovarian cancer]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=2007</guid>
		<description><![CDATA[<p class="wp-caption-text">Photo credit: People.com</p> <p>Even before the Human Genome Project blossomed with a map of all the genes in the body some genes had been identified as putting people at high risk for serious diseases such as breast and ovarian cancer. Actress Angelina Jolie is making news because she chose to have both breasts removed, [...]]]></description>
				<content:encoded><![CDATA[<div id="attachment_2008" class="wp-caption alignright" style="width: 204px"><img class="size-full wp-image-2008" alt="Angelina Jolie" src="http://blog.patientpower.info/wp-content/uploads/2013/05/Angelina-Jolie.jpg" width="194" height="259" /><p class="wp-caption-text">Photo credit: People.com</p></div>
<p>Even before the Human Genome Project blossomed with a map of all the genes in the body some genes had been identified as putting people at high risk for serious diseases such as breast and ovarian cancer. Actress <a href="http://entertainment.time.com/2013/05/14/angelina-jolie-says-she-had-double-mastectomy/" target="_blank">Angelina Jolie is making news</a> because she chose to have both breasts removed, with reconstruction with breast implants following. She made that aggressive cancer prevention choice because she was told a test result showed she carried the &#8220;breast and ovarian cancer genes: BRCA1 and BRACA2. Her mother died of breast cancer.</p>
<p>Breast removal in an otherwise healthy woman, and removal of the ovaries too, are major cancer prevention choices. But, when the genetic risk is there, it could be lifesaving and certainly lessens the fear of living with a ticking time bomb. Kudos to Ms. Jolie for going public with this.</p>
<p>It&#8217;s important to note that it is a minority of breast and ovarian cancers where a genetic cause has been identified. There may be other bad genetic predispositions at work, we just haven&#8217;t found them yet. Not long ago I hosted an audio interview program, “<a href="http://www.patientpower.info/program/genetic-testing-for-breast-and-ovarian-cancer-risk/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=breaking-news-ongoing&amp;utm_content=inline" target="_blank">Genetic Testing for Breast and Ovarian Cancer Risk</a>” with a gynecologic oncologist and her patient, who also decided to have preventive surgery. This discussion helps put the issue in perspective and explains the hard choices.</p>
<p>Angelina Jolie gets us thinking about cancer prevention, and she &#8220;took it to the max.&#8221; But people can also lower their risk of cancer in much less aggressive ways too. Being informed, and making the right choices for one’s personal situation, is always a good thing.</p>
<p>Wishing you and your family the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/05/15/angelina-jolie-cancer-prevention-to-the-max/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Today&#8217;s Cancer Experts Love Educated Patients</title>
		<link>http://blog.patientpower.info/2013/05/08/why-todays-cancer-experts-love-educated-patients/</link>
		<comments>http://blog.patientpower.info/2013/05/08/why-todays-cancer-experts-love-educated-patients/#comments</comments>
		<pubDate>Wed, 08 May 2013 17:31:45 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[ASCO 2010]]></category>
		<category><![CDATA[asco 2013]]></category>
		<category><![CDATA[claire harrison]]></category>
		<category><![CDATA[myeloproliferative disorders]]></category>
		<category><![CDATA[srdan verstovsek]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=2000</guid>
		<description><![CDATA[<p>Time is limited, and time is money, right? Doctors never seem to have enough time. As our population ages, there are more people in need of care and with spiraling higher costs doctors are required to see more patients per day. There&#8217;s little time for chit chat.</p> <p>At the same time medical science is making [...]]]></description>
				<content:encoded><![CDATA[<p>Time is limited, and time is money, right? Doctors never seem to have enough time. As our population ages, there are more people in need of care and with spiraling higher costs doctors are required to see more patients per day. There&#8217;s little time for chit chat.</p>
<p>At the same time medical science is making the practice and the treatment of serious health problems more complex. There are competing diagnostic tests, competing treatments, and many clinical trials. And empowered patients and family members want to have a consultation with their doctor, no longer accepting an &#8220;edict&#8221; telling them &#8220;this is what I am going to do.&#8221; Thankfully, people want to understand their situation and measure it against available options. Facilitating that is <a href="http://www.patientpower.info/about/mission/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=ongoing-blog&amp;utm_content=inline" target="_blank">Patient Power’s mission</a>.</p>
<p>If you think back, and as one healthcare administrator reminded me the other day, doctors used to hate it when patients asked questions. It slowed them down. They thought it showed a lack of respect. I am happy to report that in my interactions with leading medical experts, they are very open to questions and dialogue with patients like you and me. And they are making themselves very available today for our Patient Power team as we seek to interview them on video for an audience of patients worldwide. Several have agreed to be interviewed at the June meetings of the American Society of Clinical Oncology in Chicago and the European Hematology Association in Stockholm. While they share patients’ frustration that there is usually little time to have a full discussion in the exam room, and support explaining details and options to a wider audience on video and away from the crush and emotion of an office visit.</p>
<div class="wp-caption alignright" style="width: 190px"><a href="http://www.patientpower.info/video/burning-questions-what-a-researcher-is-striving-to-learn-about-mpns/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MPN-EU-2013-004-08&amp;utm_content=image"><img alt="Dr. Claire Harrison" src="http://www.patientpower.info/images/media/md/EU-2013-004-08-b1.jpg" width="180" height="150" /></a><p class="wp-caption-text">Dr. Claire Harrison</p></div>
<p>A great example is <a href="http://www.patientpower.info/video/burning-questions-what-a-researcher-is-striving-to-learn-about-mpns/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MPN-EU-2013-004-08&amp;utm_content=inline" target="_blank">Patient Power’s recent series of interviews with Professor Claire Harrison</a>, a myeloproliferative disease clinician and researcher from London. She spent 45 minutes with me giving detailed answers to questions many, many patients wish to ask about the latest research, the newest medicines, new ways of testing, what the future may hold and how soon. From my discussion with her in Madrid, when she graciously stepped out of a medical meeting with her peers, we have now edited six distinct video programs. Those are from among 18 we produced from that conference covering myelofibrosis, one of my personal diagnoses (the other is CLL), and polycythemia vera and essential thrombocythemia. Other world experts like <a href="http://www.patientpower.info/video/should-you-stop-jak2-inhibitors-if-you-become-anemic/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MPN-EU-2013-004-16&amp;utm_content=inline" target="_blank">Srdan Verstovsek</a> from MD Anderson in Houston and Drs. Passamonti, <a href="http://www.patientpower.info/video/how-next-generation-sequencing-could-improve-prognostic-factors-for-myelofibrosis/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MPN-EU-2013-004-01&amp;utm_content=inline" target="_blank">Vannucchi</a>, and Bacigalupo from Italy, and my own doctor in Spain, Cervantes, all took the time to be interviewed knowing it could reach many, many patients, they would never be able to speak with one-on-one. You can see them all together in our <a href="http://www.patientpower.info/health-topic/myeloproliferative-disorders/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=MPN-2013&amp;utm_content=inline" target="_blank">Myeloproliferative Disorders Center</a>.</p>
<p>Medical researchers and clinicians are using the media like government officials (but maybe with more credibility), to reach a wider audience in a timely way. I have also found that they understand the difference between speaking to the general media, where most of the readers and viewers do not have the condition they treat or research, and a resource like Patient Power where we are a direct line to their patients, potential patients, potential clinical trial participants, and others worldwide affected by their condition. So they graciously give a lot of their time and we are all very appreciative.</p>
<p>By the way, your doctor and nurse may well be watching the same interviews with these experts. Patient Power’s content is viewed by, and shared by, medical staff members as well as patients. In fact, on one channel specifically for oncology professionals, Patient Power videos have had some 300,000 views and we are now the third most watched channel on <a href="http://www.oncologytube.com/patientpower/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=ongoing-blog&amp;utm_content=inline" target="_blank">Oncology Tube</a>, one of our partners.</p>
<p>It’s thrilling to bring patients and caregivers current information, direct from top experts, on an ongoing basis. In the coming weeks you will see Patient Power focus more on some very specific conditions. That means some of the world renowned doctors we&#8217;ve interviewed in those conditions may become &#8220;regulars&#8221; on our videos. It&#8217;s good for you and, as noted, it&#8217;s good for them.</p>
<p>The experts are increasingly understanding we are all in this together around specific diagnoses and that modern communication 24/7 is our friend.</p>
<p>Wishing you and your family the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/05/08/why-todays-cancer-experts-love-educated-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why You Must Demand Precision Medicine for Cancer</title>
		<link>http://blog.patientpower.info/2013/04/29/why-you-must-demand-precision-medicine-for-cancer/</link>
		<comments>http://blog.patientpower.info/2013/04/29/why-you-must-demand-precision-medicine-for-cancer/#comments</comments>
		<pubDate>Mon, 29 Apr 2013 16:28:40 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[CLL]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[colin pritchard]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[human genome project]]></category>
		<category><![CDATA[mpn]]></category>
		<category><![CDATA[precision medicine]]></category>
		<category><![CDATA[SCCA]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1993</guid>
		<description><![CDATA[<p>The Human Genome Project was a really big deal, identifying the genes that make up our body. And quantum leaps in computing power, added to scientific discoveries, have been helping cancer specialists identify subtypes of disease, enabling drug developers to come up with ever more targeted therapies. More and more of these medicines for ever [...]]]></description>
				<content:encoded><![CDATA[<p>The Human Genome Project was a really big deal, identifying the genes that make up our body. And quantum leaps in computing power, added to scientific discoveries, have been helping cancer specialists identify subtypes of disease, enabling drug developers to come up with ever more targeted therapies. More and more of these medicines for ever more narrow genetic subtypes of cancer are starting to blossom with the Food and Drug Administration anointing some with <a href="http://ir.pharmacyclics.com/releasedetail.cfm?ReleaseID=754820" target="_blank">&#8220;breakthrough&#8221; status</a> and the promise of quicker approvals.</p>
<p>Major academic medical centers are now performing genetic analysis on the blood or biopsied tissue of new cancer patients. Dr. Colin Pritchard, a pathologist, <a href="http://www.patientpower.info/video/precision-medicine-new-diagnostic-tool-for-cancer-treatment/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=ongoing&amp;utm_content=inline" target="_blank">in a recent Patient Power interview</a> did a great job explaining what they do at the University of Washington and the Seattle Cancer Care Alliance. Sometimes it takes weeks, but now pathologists have more detective tools to tease out which genes may be damaged in a given cancer patient. Then they try to match that knowledge with a medicine, or combinations of medicines, that are available as approved therapy or through a clinical trial. As Dr. Pritchard explained, sometimes the genetic, molecular testing reveals unexpected results. In other words, without that knowledge a patient might have received a less effective or ineffective therapy, and suffered the side effects that go with them needlessly. Testing is being used now in some types of leukemia, melanoma, lung cancer and sarcoma, among others.</p>
<div id="attachment_1994" class="wp-caption alignright" style="width: 129px"><img class="size-full wp-image-1994" alt="Dr. Colin Pritchard" src="http://blog.patientpower.info/wp-content/uploads/2013/04/bio_colin-pritchard_scca_a.jpg" width="119" height="155" /><p class="wp-caption-text">Dr. Colin Pritchard</p></div>
<p>Molecular testing is not yet refined for many cancers. For example, in the myeloproliferative conditions (MPNs), such as myelofibrosis, it is still very much a research project. In chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) it&#8217;s more accepted and common. In myeloma we are not there yet. But the connection between genetic, molecular analysis and therapy is closing fast. My advice to a new patient is to strongly request such an analysis of their cancer situation and to inquire whether there are therapies, even in clinical trials, that line up with their specific genetic situation.</p>
<p>Researchers are very excited about delivering &#8220;precision medicine&#8221; across all cancers. Some types are more advanced, but it is coming across the board with incredible speed. The cost for analysis is coming down and the number of available targeted medicines is going up. Make sure you or your loved one gets the treatment that is most &#8220;precise.&#8221;</p>
<p>Wishing you and your family the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/04/29/why-you-must-demand-precision-medicine-for-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston Recovery: Surviving Sudden Trauma</title>
		<link>http://blog.patientpower.info/2013/04/22/boston-recovery-surviving-sudden-trauma/</link>
		<comments>http://blog.patientpower.info/2013/04/22/boston-recovery-surviving-sudden-trauma/#comments</comments>
		<pubDate>Mon, 22 Apr 2013 18:24:08 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[bill iffrig]]></category>
		<category><![CDATA[boston marathon]]></category>
		<category><![CDATA[recovery]]></category>
		<category><![CDATA[Survivorship]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1987</guid>
		<description><![CDATA[<p class="wp-caption-text">Photo Credit: John Tlumacki/The Boston Globe/AP</p> <p>The horror at the Boston Marathon finish line was felt around the world. I was shaken by the explosions in my home in Barcelona, where I now live, as I was a long-time marathoner. My son, Ari, is an elite marathon runner but opted not to run in [...]]]></description>
				<content:encoded><![CDATA[<div id="attachment_1988" class="wp-caption alignleft" style="width: 290px"><img class="size-full wp-image-1988" alt="Police officers at the finish line with runner, Bill, on the ground" src="http://blog.patientpower.info/wp-content/uploads/2013/04/Bill-the-runner.jpg" width="280" height="180" /><p class="wp-caption-text">Photo Credit: John Tlumacki/The Boston Globe/AP</p></div>
<p>The horror at the Boston Marathon finish line was felt around the world. I was shaken by the explosions in my home in Barcelona, where I now live, as I was a long-time marathoner. My son, Ari, is an elite marathon runner but opted not to run in Boston this year. Had Ari been there he would have been with his 78-year-old Seattle running club team member, <a href="http://www.huffingtonpost.com/2013/04/15/bill-iffrig-runner-boston-marathon-explosion_n_3088891.html" target="_blank">Bill Iffrig, of Lake Stevens, Wash</a>. He’s the elderly gentlemen wearing the orange singlet in a photo that went viral showing him as he was blown down by the blast. Fortunately, he was not seriously hurt. But the incidents in Boston brought death to some families and serious, long-term injuries to others, and now the healing and recovery process is underway.</p>
<p>In this blog I have written many times about people with chronic illness. We&#8217;ve given advice about getting second opinions and taking control of your &#8220;journey&#8221; right from the start. But when there&#8217;s an explosion, or a shooting, or a terrible accident, like the Texas one at the fertilizer plant, there&#8217;s no planning. In an instant you or a loved one’s health status may be changed forever. Surgeries, medications, medical devices and equipment, doctor visits, and rehabilitation may be part of your life for many years if not for the rest of your life. Like those with cancer, you become part of the world of “survivors.”</p>
<div id="attachment_1989" class="wp-caption alignright" style="width: 210px"><img class="size-full wp-image-1989" alt="Boston Strong" src="http://blog.patientpower.info/wp-content/uploads/2013/04/BostonStrong.jpg" width="200" height="200" /><p class="wp-caption-text">Photo Credit: www.baa.org</p></div>
<p>We question a lot about our healthcare system: how much things cost, is there too much marketing, can we really trust what we are being told. But when there&#8217;s a sudden event as we&#8217;ve just seen, it brings out the best in healthcare professionals and we owe them a debt of thanks.</p>
<p>Those of us living with chronic illnesses or cancer are reminded of our bond with trauma victims who are plunged into a changed life in the medical system just like we were with our diagnosis.<b> </b>And<b> </b>like Bill Iffring, the 78-year-old runner, when knocked down most of us will do all we can to get back up and get back in the race.</p>
<p>I welcome your comments and pray for a strong recovery for those who were injured.</p>
<p>Wishing you and your family the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/04/22/boston-recovery-surviving-sudden-trauma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Magic of Giving Back</title>
		<link>http://blog.patientpower.info/2013/04/08/the-magic-of-giving-back/</link>
		<comments>http://blog.patientpower.info/2013/04/08/the-magic-of-giving-back/#comments</comments>
		<pubDate>Mon, 08 Apr 2013 17:59:58 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1980</guid>
		<description><![CDATA[<p class="wp-caption-text">Marty Taft</p> <p>This is a personal story from my own family that, I believe, speaks to all of us as we age, face challenges and, hopefully, overcome them. The story is about my father-in-law, Marty Taft, a resident of Los Angeles and now 82-years young. Like many his age he has had health &#8220;interruptions.&#8221; [...]]]></description>
				<content:encoded><![CDATA[<div id="attachment_1981" class="wp-caption alignright" style="width: 250px"><a href="http://blog.patientpower.info/wp-content/uploads/2013/04/Andrew-photo-Marty-cropped.jpg"><img class="size-medium wp-image-1981" alt="Marty Taft" src="http://blog.patientpower.info/wp-content/uploads/2013/04/Andrew-photo-Marty-cropped-240x300.jpg" width="240" height="300" /></a><p class="wp-caption-text">Marty Taft</p></div>
<p>This is a personal story from my own family that, I believe, speaks to all of us as we age, face challenges and, hopefully, overcome them. The story is about my father-in-law, Marty Taft, a resident of Los Angeles and now 82-years young. Like many his age he has had health &#8220;interruptions.&#8221; One came 20 years ago when he had a heart attack. Later came a diagnosis of type 2 diabetes, like his father and brother. Fortunately, nothing stopped this former engineer as he was propelled into his senior years.</p>
<p>About ten years ago, Marty became interested in magic, so much so that he joined the <a href="http://www.magiccastle.com/" target="_blank">Magic Castle</a> in nearby Hollywood and became an associate member. Marty took delight in seeing the shows there of professional magicians and was thrilled by the amazing sleight of hand of magicians doing &#8220;close-up work&#8221; who could make things disappear.</p>
<p>Marty decided he wanted to do it too. He threw himself into it. One day he spotted a brief item in the Magic Castle newsletter. A member was looking for help performing free magic shows at area hospitals. Marty, still a novice, asked if he could watch and help. The magician, Hy Levy, welcomed him and let him perform a trick for the patients. Marty was hooked. He perfected his skills and became Hy&#8217;s regular partner. After a year, Marty passed the audition to become a Magician Member of the Magic Castle. They&#8217;ve been at it monthly now for years.</p>
<p>The other day I was in Los Angeles and accompanied Marty to his most recent performance. Hy couldn&#8217;t make it this time. These days the volunteer magicians perform for what could be considered a tough audience: men at a veteran&#8217;s hospital in a locked down mental health ward. As the activities coordinator unlocked door after door and ushered us into a group conference room I did not know what to expect. We found about 10 men of varying ages quietly waiting for us. Some seemed distracted and, I am sure, many were on some pretty heavy-duty medications. But there was a spark the moment Marty pulled out a deck of cards. The men leaned forward, some came closer. The first trick got them interested (&#8220;How did you do that?&#8221;), the next one won them over (&#8220;That&#8217;s amazing!&#8221;). Magic was the elixir for Marty and for them. Despite health issues faced by all concerned there was a childlike wonder that came into the room and, in a word, &#8220;fun.&#8221;</p>
<div id="attachment_1982" class="wp-caption alignleft" style="width: 270px"><a href="http://blog.patientpower.info/wp-content/uploads/2013/04/Magic-Castle.jpg"><img class="size-full wp-image-1982" alt="Magic Castle" src="http://blog.patientpower.info/wp-content/uploads/2013/04/Magic-Castle.jpg" width="260" height="230" /></a><p class="wp-caption-text">Photo courtesy of the Magic Castle</p></div>
<p>I got to thinking how simple magic tricks were wonderful medicine, for Marty, and for these hospitalized veterans. For years they have enabled Marty to give back and each performance brings delight to people who really need it.</p>
<p>As each of us gets through health challenges or just gets older, we may want to know if there’s some simple way we can give back to others. Marty has found his way. Patient after patient shook his hand and thanked him as the magic show ended and it’s clear Marty&#8217;s choice has made a lot of people happy.</p>
<p>Wishing you and your family the best of health,</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/04/08/the-magic-of-giving-back/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosed with Leukemia? Are You Sure?</title>
		<link>http://blog.patientpower.info/2013/04/02/diagnosed-with-leukemia-are-you-sure/</link>
		<comments>http://blog.patientpower.info/2013/04/02/diagnosed-with-leukemia-are-you-sure/#comments</comments>
		<pubDate>Tue, 02 Apr 2013 18:24:06 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[blood cancers]]></category>
		<category><![CDATA[CLL]]></category>
		<category><![CDATA[elizabeth shpall]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[Lymphoma]]></category>
		<category><![CDATA[md anderson cancer center]]></category>
		<category><![CDATA[susan o'brien]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1972</guid>
		<description><![CDATA[<p>The headlines each day bring more good news about progress in treating blood cancers. We now know more than ever before about leukemia, lymphoma, myeloma and other disorders. There used to be a fairly standard approach to treatment, but that’s changed too. There are many subtypes and new therapies, new drug combinations, various clinical trial [...]]]></description>
				<content:encoded><![CDATA[<p>The headlines each day bring more good news about progress in treating blood cancers. We now know more than ever before about leukemia, lymphoma, myeloma and other disorders. There used to be a fairly standard approach to treatment, but that’s changed too. There are many subtypes and new therapies, new drug combinations, various clinical trial options and even uses of transplant vary depending upon the individual patient situation. One thing has not changed however: Receiving an accurate diagnosis at the start is absolutely critical.</p>
<div id="attachment_1973" class="wp-caption alignleft" style="width: 129px"><img class="size-full wp-image-1973" alt="Susan O'Brien, MD" src="http://blog.patientpower.info/wp-content/uploads/2013/04/Susan_Obrien1.jpg" width="119" height="155" /><p class="wp-caption-text">Susan O&#8217;Brien, MD</p></div>
<p>Starting off with the wrong treatment could 1) Not be effective and/or bring needless side effects 2) Make things much worse and 3) Preclude the patient from a better approach, as in a trial. This means even doing a lot of online research to become educated may not be enough. It&#8217;s a tough time for patients and caregivers because a well-meaning general oncologist or hematologist may be saying treatment is needed immediately. Sometimes that is true, but often there is time to get to a renowned specialist at a center where they see multiple types of blood cancers all the time and also research them. As is often said in cancer care, &#8220;Your first shot is your best shot.&#8221;</p>
<p>The other day I received an email from a Patient Power visitor who was sparked to write after we featured a new interview with the specialist he says saved his life, <a href="http://www.patientpower.info/video/b-cell-receptor-agents-is-this-the-road-to-a-cure-for-cll/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=ongoing&amp;utm_content=inline" target="_blank">Dr. Susan O&#8217;Brien</a> from MD Anderson Cancer Center in Houston. Jim (last named withheld by request) explained how, in 1998, he was told by three Chicago doctors he had a serious version of chronic lymphocytic leukemia (CLL) and should prepare himself to have a stem cell transplant.</p>
<p>Jim didn’t accept that and went searching online, where he found the <a href="http://www.acor.org/" target="_blank">CLL patient community on acor.org</a>. ACOR, for those not familiar with it, is the Association of Cancer Online Resources, founded in 1996, and is made up of communities of patients with many types of cancers. The leader of the CLL group back then, GrannyBarb Lackritz, told Jim the same thing she told me. &#8220;Get yourself to a CLL specialist. Get another opinion.&#8221;</p>
<p>Jim did and saw Dr. O&#8217;Brien who, after pondering his case, decided he had something different: Splenic Lymphoma with Villous Lymphocytes (SLVL) – obviously not something a community oncologist would see every day! This rare disorder comprises less than one percent of lymphoid neoplasms. SLVL is often confused with CLL and sometimes with hairy cell leukemia.</p>
<p>Jim had no chemo and no transplant. Instead, he had a splenectomy and his health was pretty good for the next 11 years. In 2009 Jim needed Dr. O&#8217;Brien again. He had pain, large lumps in his groin and high blood counts. This time it was &#8220;marginal zone lymphoma.&#8221; Treatment was chemo, an allogeneic transplant from his brother, and more radiation. Jim came to love Dr. O&#8217;Brien – again &#8211; and his transplant doctor, <a href="http://faculty.mdanderson.org/Elizabeth_Shpall/" target="_blank">Elizabeth Shpall</a>, also with MD Anderson. He affectionately calls them &#8220;Velma and Roxy,” after characters from the play and movie, “Chicago.”</p>
<div id="attachment_1974" class="wp-caption alignright" style="width: 124px"><img class="size-full wp-image-1974" alt="Elizabeth Shpall, MD" src="http://blog.patientpower.info/wp-content/uploads/2013/04/Elizabeth-Shpall.jpg" width="114" height="173" /><p class="wp-caption-text">Elizabeth Shpall, MD</p></div>
<p>Jim told Dr. Shpall his dream was to ski again. As a skier herself, she said she understood and assured him he would do that. I’m happy to report that since June of 2010 Jim has been working and leading a normal life that includes gardening and bicycling with his partner, Gary, and yes, skiing recently for a week in Vail.</p>
<p>So think about this: Jim&#8217;s cancer journey began 15 years ago and now he is living well. Would he have had this result if he had started off with the wrong diagnosis? I do not think so. For sure, there are people with &#8220;classic&#8221; cases of a leukemia that most hematologist/oncologists know well, but from the patient&#8217;s perspective it is critical to feel confident you have the right diagnosis and the most up-to-date treatment plan. There&#8217;s too much risk if the initial diagnosis is wrong. And, adding to that, patients also need to make sure clinical trials are part of the treatment option discussions, even during the initial stages. In these times when things are changing fast, you should hear whether you might be a candidate for what could be &#8220;tomorrow&#8217;s medicine&#8221; today – even if the doctor who is telling you does not have a trial available at his/her center.</p>
<p>Jim&#8217;s special person, Dr. O&#8217;Brien, is tops in our book too. That’s why you will find new interviews with her, and other top blood cancer specialists, on Patient Power. Knowledge was definitely the best medicine for Jim 15 years ago, and that is still true today.</p>
<p>Wishing you and your family the best of health,</p>
<p>Andrew</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/04/02/diagnosed-with-leukemia-are-you-sure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Back to School: An Ongoing Need for Patients</title>
		<link>http://blog.patientpower.info/2013/03/22/back-to-school-an-ongoing-need-for-patients/</link>
		<comments>http://blog.patientpower.info/2013/03/22/back-to-school-an-ongoing-need-for-patients/#comments</comments>
		<pubDate>Fri, 22 Mar 2013 20:56:39 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[human genome project]]></category>
		<category><![CDATA[MD Anderson]]></category>
		<category><![CDATA[mmore]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[personalized medicine]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1966</guid>
		<description><![CDATA[<p>It’s tough to be a cancer patient today. Not just because you have cancer, but because you have to do a lot of work to ensure you have knowledgeable doctors, the best care, and that you do your part.</p> <p>The human genome project has ushered in the age of &#8220;precision medicine.&#8221; Cancer centers around the [...]]]></description>
				<content:encoded><![CDATA[<p><img class="alignright size-medium wp-image-1967" title="Myeloma conference" src="http://blog.patientpower.info/wp-content/uploads/2013/03/MORE_220-227x300.jpg" alt="" width="227" height="300" />It’s tough to be a cancer patient today. Not just because you have cancer, but because you have to do a lot of work to ensure you have knowledgeable doctors, the best care, and that you do your part.</p>
<p>The human genome project has ushered in the age of &#8220;precision medicine.&#8221; Cancer centers around the world are leveraging vastly cheaper approaches to analyzing the genetic profiles of a new patient&#8217;s cancer. At the same time upstart biotech firms have been developing an increased parade of &#8220;targeted therapies,&#8221; many of them in the form of expensive pills. The changes can be bewildering for doctors and they certainly are for patients who have the overlay of fear.</p>
<p>The other day I hosted a <a href="http://www.patientpower.info/events/living-well-with-myeloma-experts-perspectives-on-what-new-options-mean-for-you/?utm_source=andrews-blog&amp;utm_medium=blog&amp;utm_campaign=ongoing&amp;utm_content=inline" target="_blank">town meeting</a> on behalf of <a href="http://www.mmore.org/" target="_blank">MMORE</a> (Multiple Myeloma Opportunities for Education and Research). It was held at MD Anderson Cancer Center in Houston and 200 patients and caregivers turned out. They heard from experts including myeloma mentor patients Paul Rabuck and Eunice Marks; Thomas Martin, M.D. from UCSF; and Robert Orlowski, M.D. and Brianna Garrison, Licensed Master Social Worker, both from MD Anderson. They also came to meet others with the same health concern. The clinical part of the discussion took more than an hour as the doctors took us through the vast changes in treatments, research and side effect management. The audience took copious notes.</p>
<p>The discussion will continue in support groups, social media, advocacy groups and on the Patient Power site. The good news is there is lots to talk about and clearly, with some cancers – unfortunately, not all – people are living longer and better. But it takes work and some sophistication to cut through the clutter of old information and wrong or misleading information.</p>
<p><img class="alignleft size-medium wp-image-1968" title="Myeloma conference" src="http://blog.patientpower.info/wp-content/uploads/2013/03/MORE_388-300x233.jpg" alt="" width="300" height="233" />That was apparent to me when I went to Los Angeles after Houston. While I was driving there, and listening to the radio, the airwaves were filled with ads for area cancer centers. It&#8217;s big business. The ads especially plugged technology, new million dollar radiation devices and the stories of grateful patients.</p>
<p>If only it were that simple: go to the hospital that &#8220;cares&#8221; about you and has the gleaming machines. But in this age of precision medicine that is far from enough. It is unlikely even the slickest center has the best doctor for every cancer. They may lack the latest expertise and the availability of a clinical trial that might give you the hope of receiving tomorrow&#8217;s medicine today – and there are a lot of promising medicines in research.</p>
<p>That&#8217;s why you have to be a savvy patient and do your homework. You have to seek out the experts and weigh what they say against what is being offered. You have to be discriminating. And, in cancer, it&#8217;s doubly important because if you get the wrong treatment first you may be harmed and precluded from the right therapy later on. You can&#8217;t always recoup. I am devoted to connecting patients with unbiased information and helping them become students of their disease.</p>
<p>Let’s applaud the patients who attended our town meeting: becoming educated is critical for anyone facing cancer today. No one dreams of taking a college-type course in an illness but, to get the best care today, it&#8217;s a wise approach.</p>
<p>Wishing you the best of health,</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/03/22/back-to-school-an-ongoing-need-for-patients/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Why New Standards Are Needed for Faster Cancer Drug Approvals</title>
		<link>http://blog.patientpower.info/2013/03/04/why-new-standards-are-needed-for-faster-cancer-drug-approvals/</link>
		<comments>http://blog.patientpower.info/2013/03/04/why-new-standards-are-needed-for-faster-cancer-drug-approvals/#comments</comments>
		<pubDate>Mon, 04 Mar 2013 21:36:17 +0000</pubDate>
		<dc:creator>a.schorr</dc:creator>
				<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1956</guid>
		<description><![CDATA[<p>Several years ago I attended an FDA Oncology Drug Advisory Committee (ODAC) hearing. What the medical experts and the FDA regulators wanted to know most was did a proposed new cancer medicine help people live longer? Not better, just longer. The CLL (chronic lymphocytic leukemia) drug in question that day was not recommended for approval [...]]]></description>
				<content:encoded><![CDATA[<p>Several years ago I attended an FDA Oncology Drug Advisory Committee (ODAC) hearing. What the medical experts and the FDA regulators wanted to know most was did a proposed new cancer medicine help people live longer? Not better, just longer. The CLL (chronic lymphocytic leukemia) drug in question that day was not recommended for approval because they never could show a &#8220;survival advantage.&#8221; I think the small biotech that made the drug ended up being closed down. Fortunately, the FDA has approved some other cancer drugs since then where they&#8217;ve helped people live better. I take one, Jakafi for myelofibrosis, which greatly reduces symptoms but there&#8217;s no clear data yet that people live longer because of it. So thanks to the FDA for becoming more enlightened. But now there&#8217;s a need to move still further ahead.</p>
<p><img class="alignright size-medium wp-image-1957" title="Diagnostics, Stethoscope, Pen, Photo_jpg" src="http://blog.patientpower.info/wp-content/uploads/2013/03/Diagnostics-Stethoscope-Pen-Photo_jpg-300x225.jpg" alt="" width="300" height="225" /></p>
<p>In some cancer conditions people are living for many years WITH cancer before they eventually succumb. Biochemically recurrent prostate cancer can be like that. There&#8217;s evidence the cancer has spread but it&#8217;s not obvious where. Another case is in CLL where people with less aggressive subtypes may have had treatment but then be in remission for several years. So here&#8217;s the regulatory problem: if people are going to live several or many years with a cancer, how can you early on a measure the effectiveness of a proposed new drug that might help them live longer? In prostate cancer and CLL, to name two examples, that&#8217;s the dilemma. There MAY be a &#8220;survival advantage,&#8221; for example for one of these promising new &#8220;small molecule&#8221; pills now in trials, or even a new drug that&#8217;s been approved, as in prostate cancer. But you need a test the FDA and other regulatory bodies will accept as a &#8220;surrogate&#8221; for how long someone lives.</p>
<p>In an <a href="http://www.patientpower.info/video/the-new-landscape-in-metastatic-castration-resistant-prostate-cancer-research-and-treatment/?autoplay=1&amp;utm_source=andrews-blog&amp;utm_medium=link&amp;utm_campaign=prostate-2013&amp;utm_content=inline" target="_blank">interview with Dr. Celestia Higano</a>, a prostate cancer expert, she tells me about just that. And in another interview, with Dr. Peter Hillmen, a CLL expert, he said he is going before the FDA to ask that sensitive tests for MRD (minimal residual disease) be acceptable measures. The idea is new tests, or ones that should be developed, can be an acceptable measure of whether a potential new drug will extend life.</p>
<p>My view is the FDA, and other agencies around the world, should work collaboratively with industry and scientists to expeditiously assess if a potential new drug is worth approval. If new tests can speed things up then let&#8217;s agree on them and use them.</p>
<p>As some cancers are now becoming more like chronic conditions where you live with them rather than dying fairly quickly from them, we need a new system to measure how lasting &#8220;chronic&#8221; is.</p>
<p>I welcome your comments.</p>
<p>Wishing you and your family the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/03/04/why-new-standards-are-needed-for-faster-cancer-drug-approvals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are New &#8220;Quality of Life Drugs&#8221; Worth the Expense?</title>
		<link>http://blog.patientpower.info/2013/02/19/are-new-quality-of-life-drugs-worth-the-expense/</link>
		<comments>http://blog.patientpower.info/2013/02/19/are-new-quality-of-life-drugs-worth-the-expense/#comments</comments>
		<pubDate>Wed, 20 Feb 2013 00:14:46 +0000</pubDate>
		<dc:creator>b.blankinship</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[quality of life]]></category>

		<guid isPermaLink="false">http://blog.patientpower.info/?p=1948</guid>
		<description><![CDATA[<p>Very recently a review committee in the U.K. made a preliminary recommendation that the government&#8217;s National Health Service should not pay for a newly approved medicine that greatly reduces or alleviates the symptoms of myelofibrosis (MF). MF develops when there is progressive scarring in the bone marrow that affects one&#8217;s ability to make blood cells. [...]]]></description>
				<content:encoded><![CDATA[<p><img class="alignright size-medium wp-image-1954" title="Andrew Toasting" src="http://blog.patientpower.info/wp-content/uploads/2013/02/426164_10152591260725121_1784075562_n-300x223.jpg" alt="" width="300" height="223" />Very recently a review committee in the U.K. made a preliminary recommendation that the government&#8217;s National Health Service should not pay for a newly approved medicine that greatly reduces or alleviates the symptoms of myelofibrosis (MF). MF develops when there is progressive scarring in the bone marrow that affects one&#8217;s ability to make blood cells. Other organs like the spleen and liver try to take over the job and they become enlarged. Along with that, a patient experiences itching, fatigue and weight loss, as well as general malaise and suffering. While a new oral medicine, Jakafi in the U.S. and Jakavi in Europe, has not been proven to reduce or reverse the scarring (fibrosis), most patients feel the drug gives them back a full and productive life. However, it&#8217;s very expensive, more than $7,000 a month.</p>
<p>I know all about this personally, since I was officially diagnosed with MF nine months ago and began taking the medicine as symptoms developed last fall. It has worked wonders. I thank my lucky stars that my U.S. private insurance pays for it. It allows me to be productive, support my family and contribute to others. My belief is that the expenditure is worth it not only for me, but for society. By helping me feel good I can work, pay taxes and support others.</p>
<p>The UK panel faces tough choices. Money spent on a &#8220;quality of life&#8221; drug has to come from somewhere in the health system. I understand that. I also understand these drugs are priced very high to bring a return on investment to the pharmaceutical company, often initially a smaller one that took the risk to develop an important new medicine. In this case, the pre-existing treatments are not very effective.</p>
<p>It would be great if this new drug can be shown in the long run to treat and reverse the underlying disease or significantly lengthen survival. So far there is no evidence for that. Fortunately, other drugs, perhaps used in combination, may lead to that result. But, in the meantime, should the UK, and possibly other government health systems, force patients to suffer when breakthrough medicines exist?</p>
<p>Fortunately, the decision is not final yet and there is a period of comment until June. My hope is the pharmaceutical company, advocates, patients, and the government can all reach a middle ground. Knowing how this &#8220;quality of life&#8221; drug has allowed me to live a full life, I would hate it if that opportunity is denied to my brothers and sisters in the U.K. or anywhere else.</p>
<p>What are your views on the tough choices for paying for such treatments in these tight economic times?</p>
<p>Wishing you the best of health!</p>
<p>Andrew</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.patientpower.info/2013/02/19/are-new-quality-of-life-drugs-worth-the-expense/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
